Press release
Top Players and Competitive Dynamics in the Cardiogenomics Market
The cardiogenomics sector is on the brink of significant expansion, driven by advancements in genomic technologies and personalized medicine. As heart-related diseases continue to pose major health challenges, this market is poised to deliver innovative solutions that tailor cardiac care to individual genetic profiles. Let's explore the current projections, influential companies, evolving trends, and segmentation details shaping this promising field.Projected Market Growth and Size for Cardiogenomics by 2030
The cardiogenomics market is anticipated to experience swift growth over the next several years, reaching a market size of $3.57 billion by 2030. This surge corresponds to an impressive compound annual growth rate (CAGR) of 15.4%. Factors fueling this expansion include increasing demand for personalized cardiac care, the broadening scope of precision medicine initiatives, boosted investments in genomic research, and greater adoption of AI-powered genomic analysis. Additionally, the integration of genomics into routine cardiology practice is becoming more widespread. Key trends expected to shape the market include rising utilization of genetic risk profiling, enhanced use of next-generation sequencing in cardiovascular research, incorporation of bioinformatics platforms, expanded personalized treatment strategies, and a stronger focus on preventive genomic screening.
Download a free sample of the cardiogenomics market report:
https://www.thebusinessresearchcompany.com/report/cardiogenomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Prominent Players Leading the Cardiogenomics Market
The cardiogenomics industry features several influential companies that dominate the landscape. These include Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., and UAB Cardiogenomics Clinic.
Significant Acquisition Enhancing Market Capabilities
In March 2025, Tempus AI Inc., a US-based technology firm, acquired Ambry Genetics Corporation for an undisclosed sum. This strategic acquisition aims to combine Ambry's expertise in genetic testing and precision medicine with Tempus AI's advanced data analytics powered by artificial intelligence. The move is intended to broaden Tempus AI's precision medicine offerings, improve patient outcomes, and deliver comprehensive personalized healthcare solutions across various disease areas, including cardiogenomics. Ambry Genetics is known for its specialized genetic testing services within the cardiogenomics field.
The cardiogenomics sector is on the brink of significant expansion, driven by advancements in genomic technologies and personalized medicine. As heart-related diseases continue to pose major health challenges, this market is poised to deliver innovative solutions that tailor cardiac care to individual genetic profiles. Let's explore the current projections, influential companies, evolving trends, and segmentation details shaping this promising field.
Projected Market Growth and Size for Cardiogenomics by 2030
The cardiogenomics market is anticipated to experience swift growth over the next several years, reaching a market size of $3.57 billion by 2030. This surge corresponds to an impressive compound annual growth rate (CAGR) of 15.4%. Factors fueling this expansion include increasing demand for personalized cardiac care, the broadening scope of precision medicine initiatives, boosted investments in genomic research, and greater adoption of AI-powered genomic analysis. Additionally, the integration of genomics into routine cardiology practice is becoming more widespread. Key trends expected to shape the market include rising utilization of genetic risk profiling, enhanced use of next-generation sequencing in cardiovascular research, incorporation of bioinformatics platforms, expanded personalized treatment strategies, and a stronger focus on preventive genomic screening.
Download a free sample of the cardiogenomics market report:
https://www.thebusinessresearchcompany.com/report/cardiogenomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Prominent Players Leading the Cardiogenomics Market
The cardiogenomics industry features several influential companies that dominate the landscape. These include Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., and UAB Cardiogenomics Clinic.
Significant Acquisition Enhancing Market Capabilities
In March 2025, Tempus AI Inc., a US-based technology firm, acquired Ambry Genetics Corporation for an undisclosed sum. This strategic acquisition aims to combine Ambry's expertise in genetic testing and precision medicine with Tempus AI's advanced data analytics powered by artificial intelligence. The move is intended to broaden Tempus AI's precision medicine offerings, improve patient outcomes, and deliver comprehensive personalized healthcare solutions across various disease areas, including cardiogenomics. Ambry Genetics is known for its specialized genetic testing services within the cardiogenomics field.
Innovations and Future Trends in Cardiogenomics
Leading companies in the cardiogenomics market are prioritizing the development of cutting-edge products to enhance treatment outcomes. One such innovation is the cryoprobe, a device used in cryotherapy to apply extreme cold to targeted tissues for therapeutic purposes, such as treating tumors or lesions. For example, in May 2023, Varian, a Siemens Healthineers company, introduced the Isolis cryoprobe. This single-use, disposable device is designed to improve precision and efficiency during cryoablation procedures. It offers interventional radiologists enhanced control with its sharp tip and can be integrated with the Siemens Healthineers myNeedle Laser guidance system to ensure accurate placement of the probe.
Detailed Segmentation of the Global Cardiogenomics Market
This report segments the cardiogenomics market comprehensively by various dimensions:
1) Product Type: Testing Kits, Reagents, Instruments, Software, and Services
2) Technology: Next-Generation Sequencing, Polymerase Chain Reaction (PCR), Microarray, and Other Technologies
3) Application: Congenital Heart Diseases, Cardiomyopathies, Arrhythmias, Coronary Artery Disease, and Other Applications
4) End-User: Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, and Other End-Users
Further subcategories include:
- Testing Kits: PCR kits, Microarray kits, NGS kits
- Reagents: Enzymes, Probes, Buffers
- Instruments: Sequencers, Genotyping instruments, Microarray Scanners
- Software: Data Analysis Software, Reporting Platforms, Bioinformatics Tools
- Services: Genetic Testing Services, Counseling Services, Data Analysis Services
This detailed segmentation allows a clear understanding of the cardiogenomics market structure and its multifaceted growth potential across product types, technologies, applications, and user groups.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Players and Competitive Dynamics in the Cardiogenomics Market here
News-ID: 4462370 • Views: …
More Releases from The Business Research Company
Key Players and Competitive Overview in the Cell and Gene Therapy Manufacturing …
The cell and gene therapy manufacturing services sector is on the cusp of remarkable expansion, driven by innovations and increasing demand for advanced therapies. With the rise of personalized medicine and growing industry investments, this market is set to witness substantial growth in the coming years. Let's delve into the market size projections, key players, emerging trends, and segment breakdowns that define this evolving industry.
Projected Growth and Market Size of…
Outlook on the Catalepsy Treatment Market: Major Segments, Strategic Development …
The landscape of catalepsy treatment is on the verge of significant expansion as advancements in medical research and growing awareness around neurological health reshape the market. Increasing innovation in therapeutic approaches and the rise of personalized care are setting the stage for this market's robust growth over the coming years. Let's explore the anticipated market valuation, key players, emerging trends, and detailed segment insights shaping the future of catalepsy treatment.
Projected…
Emerging Sub-Segments Transforming the Care Services Market Landscape
The care services market is on the verge of experiencing considerable growth as healthcare continues to evolve with technological advancements and shifting patient demands. This sector is adapting quickly to incorporate new models of care delivery and innovative solutions that prioritize patient well-being and convenience. Let's explore the current market size, key drivers, major players, prominent trends, and segmentation that define this rapidly expanding industry.
Projected Size and Growth Trajectory of…
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the C …
The cardiac mapping market is gaining considerable attention as advancements in technology and treatment options evolve. This sector is poised for notable growth driven by innovations that enhance the precision and effectiveness of cardiac procedures. Below is a detailed overview of the market size, key players, influential trends, and segmentation that define the current and future landscape of cardiac mapping.
Estimating the Cardiac Mapping Market Size by 2030
The cardiac mapping…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
